New York – The Structure of Complex ‘Respiratory Tract Diseases of the Modena University Hospital, directed by Leonardo Fabbri, took part in an international study coordinated by researchers from Cornell University, Liverpool, Kiel, in collaboration with Industria Takeda. The goal was to test a drug against chronic obstructive pulmonary disease (COPD) that opens concrete prospects of less invasive therapies to reduce exacerbations and hospitalizations. The study, published under the title “Roflumilast for Exacerbations in patients receiving Appropriate Combination Therapy (REACT)” involved 1,945 patients examined in 203 clinical centers in 21 countries, featured in The Lancet, one of the most prestigious scientific journals in the world. (9Colonne)
